A preclinical study by scientists at Scripps Research finds that a drug already FDA-approved for treating inflammatory ...

A preclinical study from scientists at Scripps Research finds that a apremilast, a drug already FDA-approved for treating ...

Scientists at Scripps Research discover that apremilast, an FDA-approved anti-inflammatory drug, reduces both alcohol ...

Objective: To review available literature evaluating the pharmacology, pharmacokinetics, clinical efficacy, and adverse effects of cilomilast, a selective phosphodiesterase-4 (PDE4) inhibitor.

AD is a growing market with an impressive pipeline of new products from current and future players in the field.

However, traditional PDE4 inhibitors may cause adverse effects ... which are particularly advantageous for drug discovery. LW, a derivative of the natural product Moracin M, was found to have ...

The results, published in JCI Insight on April 22, 2025, suggest that the drug apremilast -- a phosphodiesterase-4 (PDE4) inhibitor, or a compound that blocks an enzyme involved in inflammation ...

Explore how apremilast could offer anti-inflammatory benefits in treating alcohol use disorder and chronic pain effectively.